EyePoint Pharmaceuticals
EYPT
#10613
Rank
โ‚น2.46 B
Marketcap
โ‚น21.70
Share price
-11.36%
Change (1 day)
-98.23%
Change (1 year)

EPS for EyePoint Pharmaceuticals (EYPT)

EPS in 2026 (TTM): -โ‚น344.24

According to EyePoint Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น346.55. In 2025 the company made an earnings per share (EPS) of -โ‚น292.81 a decrease over its 2024 EPS that were of -โ‚น214.04.

EPS history for EyePoint Pharmaceuticals from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น344.2417.57%
2025-โ‚น292.8136.8%
2024-โ‚น214.04
2022-โ‚น252.9635.15%
2021-โ‚น187.17-42.45%
2020-โ‚น325.24-37.32%
2019-โ‚น518.90-57.89%
2018-โ‚น1,232125.42%
2017-โ‚น546.696.89%
2016-โ‚น511.45-20.01%
2015-โ‚น639.35
2013-โ‚น518.9021.74%
2012-โ‚น426.24-58.18%
2011-โ‚น1,019

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น5.56-98.40% Bahamas
NRC Health
NRC
โ‚น26.87-107.75%๐Ÿ‡บ๐Ÿ‡ธ USA